Chi Zhang
@chizhang98.bsky.social
Reposted by Chi Zhang
Exciting days at the G-JAM meeting hosted by the Fritz-Lipmann-Institut in Jena 🇩🇪! Our PhDs and Postdocs presented their latest work on cellular senescence and connected with an inspiring community of aging researchers. Many thanks to the organizers for such a stimulating event! 💥🧬 #aging #research
October 5, 2025 at 5:01 PM
Exciting days at the G-JAM meeting hosted by the Fritz-Lipmann-Institut in Jena 🇩🇪! Our PhDs and Postdocs presented their latest work on cellular senescence and connected with an inspiring community of aging researchers. Many thanks to the organizers for such a stimulating event! 💥🧬 #aging #research
Reposted by Chi Zhang
🚨 Big news! 🚨 Our lab's latest paper by Jamil Nehme (@jamilnehme.bsky.social) is out now:
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer.
Check it out! (doi.org/10.1038/s443...) Congrats, Jamil! #CancerResearch #CDK46 #BreastCancer
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer.
Check it out! (doi.org/10.1038/s443...) Congrats, Jamil! #CancerResearch #CDK46 #BreastCancer
February 10, 2025 at 4:12 PM
🚨 Big news! 🚨 Our lab's latest paper by Jamil Nehme (@jamilnehme.bsky.social) is out now:
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer.
Check it out! (doi.org/10.1038/s443...) Congrats, Jamil! #CancerResearch #CDK46 #BreastCancer
Pharmacological CDK4/6 inhibition promotes vulnerability to lysosomotropic agents in breast cancer.
Check it out! (doi.org/10.1038/s443...) Congrats, Jamil! #CancerResearch #CDK46 #BreastCancer